Filing Details
- Accession Number:
- 0001209191-19-011851
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-20 20:47:58
- Reporting Period:
- 2019-02-15
- Accepted Time:
- 2019-02-20 20:47:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1299130 | Pacific Biosciences Of California Inc. | PACB | Laboratory Analytical Instruments (3826) | 161590339 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504238 | Michael James Phillips | Pacific Biosciences Of California, Inc. 1305 O'Brien Drive Menlo Park CA 94025 | Svp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-15 | 8,000 | $0.00 | 223,156 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-02-15 | 13,605 | $0.00 | 236,761 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-02-19 | 7,231 | $7.17 | 229,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date.
- Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units.
- Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards.
- This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
